Walgreens improving pharmacy business and comments from the company’s CEO are convincing Wall Street that the drugstore won't ...

The diamond-encrusted masterpiece is a tribute to the company's 192-year history and the countless employees who have served it ...

Revenue came to $39 billion for the fiscal quarter ended in November, driven by higher prices for branded drugs and ...

Walgreens reported a $265 million quarterly loss while citing what the company’s chief executive called “early progress” en ...

Walgreens is expected to report in-line earnings for the first fiscal quarter of 2025 amid a backdrop of ongoing take-private talks.

Investors are eager to hear updates about potential buyout talks with Sycamore Partners, which have been ... the company has implemented since CEO Tim Wentworth took over in 2023.

In December, word spread that Walgreens Boots Alliance Inc. (Nasdaq: WBA) was reportedly considering selling itself to the PE firm Sycamore Partners. A ...

Walgreens, like other companies in the retail pharmacy space, has struggled with challenges related to low reimbursement and ...

Walgreens' shares jumped Friday, despite a $265 million loss in the latest quarter, as the drugstore chain also posted better sales and adjusted profits than analysts expected. | Walgreens' shares ...